IN2014KN02914A - - Google Patents

Info

Publication number
IN2014KN02914A
IN2014KN02914A IN2914KON2014A IN2014KN02914A IN 2014KN02914 A IN2014KN02914 A IN 2014KN02914A IN 2914KON2014 A IN2914KON2014 A IN 2914KON2014A IN 2014KN02914 A IN2014KN02914 A IN 2014KN02914A
Authority
IN
India
Prior art keywords
appendages
epidermis
imbalance
proliferation
differentiation
Prior art date
Application number
Inventor
Xavier Marat
Benoit Muller
Agnes Thomas-Collignon
Dominique Bernard
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of IN2014KN02914A publication Critical patent/IN2014KN02914A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The present invention relates to the cosmetic use, as agent for preventing and/or treating an aesthetic defect in the skin and/or its appendages that is associated with an imbalance in the differentiation and/or proliferation of the cells of an epidermis, of an effective amount of at least one compound represented by one of the general formulae, (Ia) or (Ib).
IN2914KON2014 2012-06-06 2013-06-05 IN2014KN02914A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1255267A FR2991578B1 (en) 2012-06-06 2012-06-06 COMPOUNDS FOR ANTI-AGING AND DRY SKIN APPLICATION
PCT/IB2013/054635 WO2013183017A1 (en) 2012-06-06 2013-06-05 Compounds for dry skin and anti-ageing application

Publications (1)

Publication Number Publication Date
IN2014KN02914A true IN2014KN02914A (en) 2015-05-08

Family

ID=47227885

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2914KON2014 IN2014KN02914A (en) 2012-06-06 2013-06-05

Country Status (9)

Country Link
US (1) US9464080B2 (en)
EP (1) EP2858624B1 (en)
JP (1) JP6257603B2 (en)
CN (1) CN104507455B (en)
BR (1) BR112014030553B1 (en)
ES (1) ES2603390T3 (en)
FR (1) FR2991578B1 (en)
IN (1) IN2014KN02914A (en)
WO (1) WO2013183017A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2968201B1 (en) * 2010-12-07 2017-07-21 Oreal SASPASE-FLG2 COMPLEX, MODULATING AGENTS AND USES
FR2991578B1 (en) 2012-06-06 2019-12-27 L'oreal COMPOUNDS FOR ANTI-AGING AND DRY SKIN APPLICATION
FR3029413B1 (en) 2014-12-05 2018-03-09 L'oreal AQUEOUS DISPERSION OF ANTI-AGING COMPOUND AND COSMETIC COMPOSITION COMPRISING THE SAME
JP7237465B2 (en) * 2018-05-25 2023-03-13 ポーラ化成工業株式会社 A screening method using the expression levels of the occludin gene, the claudin gene, and the zo-1 gene under hypoxic conditions as an indicator, an inhibitor of claudin gene expression reduction, an inhibitor of cell adhesion apparatus function deterioration, and a reduction in skin barrier function ameliorating or preventive agent
FR3111807B1 (en) 2020-06-30 2022-11-25 Oreal Use of pyrido-pyrimidine-trione derivative compounds as agents preventing or reducing the adhesion of microorganisms to the skin and/or mucous membranes
US20220380674A1 (en) * 2021-05-18 2022-12-01 Ticona Llc Photoplethysmographic Sensor Containing A Polymer Composition
CN114397392B (en) * 2022-01-18 2023-08-11 宁波中盛产品检测有限公司 Ion chromatography analysis method for vitronectin effective matters in cosmetics

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1060183A (en) 1951-07-07 1954-03-31 Beam or joist placed on several supports, for roofs, roofs or similar constructions
FR1060179A (en) 1952-07-05 1954-03-31 Rech S Et D Applic Physicochim Device for supporting and fixing isolated objects and more particularly electric capacitors or the like
JPS59225188A (en) * 1983-06-02 1984-12-18 Takeda Chem Ind Ltd Condensed pyrimidine derivative and its preparation
NZ516873A (en) * 2001-02-12 2003-11-28 Warner Lambert Co Compositions containing retinoids and erb inhibitors and their use in inhibiting retinoid skin damage
PA8539401A1 (en) * 2001-02-14 2002-10-28 Warner Lambert Co QUINAZOLINAS AS INHIBITORS OF MMP-13
EP2266984A1 (en) * 2009-06-26 2010-12-29 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Pyrido[2,3-d]pyrimidines as Wnt antagonists for treatment of cancer and arthritis
AT511259A3 (en) 2011-02-23 2012-12-15 Pharma Consult Ges M B H & Co Nfg Kg INJECTION SPRAY HEAD, SPRING UNIT, AND INJECTION SPREADING THEREFOR
FR2991578B1 (en) 2012-06-06 2019-12-27 L'oreal COMPOUNDS FOR ANTI-AGING AND DRY SKIN APPLICATION

Also Published As

Publication number Publication date
EP2858624A1 (en) 2015-04-15
WO2013183017A1 (en) 2013-12-12
FR2991578B1 (en) 2019-12-27
ES2603390T3 (en) 2017-02-27
BR112014030553A2 (en) 2017-06-27
FR2991578A1 (en) 2013-12-13
CN104507455B (en) 2020-08-04
CN104507455A (en) 2015-04-08
JP6257603B2 (en) 2018-01-10
US9464080B2 (en) 2016-10-11
JP2015518878A (en) 2015-07-06
BR112014030553B1 (en) 2020-11-17
US20150148356A1 (en) 2015-05-28
EP2858624B1 (en) 2016-08-24

Similar Documents

Publication Publication Date Title
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
IN2014KN02914A (en)
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
MX2021014709A (en) Methods for increasing red blood cell levels and treating sickle-cell disease.
IN2014DN07763A (en)
PH12015501576A1 (en) Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith
MX355080B (en) Improving skin appearance with increase in skin chroma.
MX2020010535A (en) Methods of treating cancer.
BR112015011933A2 (en) synergistic bacterial compositions and methods of production and use thereof
MX2014012477A (en) Pyrrolopyrazone inhibitors of tankyrase.
TW201611843A (en) Methods of treatment with arginine deiminase
MX342947B (en) Treatment of type 2 diabetes.
IN2014DN06104A (en)
EA201400748A1 (en) COMPOSITION FOR PROCESSING SEEDS
MX2016006975A (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases.
PH12015502405A1 (en) Methods and compositions for wound healing
MY179576A (en) Agent for promoting in vivo absorption of hydroxytyrosol and derivatives thereof and use of same
MX359181B (en) Collagen hydrolysate and use thereof.
MX2014010940A (en) The use of antithrombin in the treatment of pre-eclampsia.
HRP20170198T1 (en) Compositions containing chondroitin sulphate, nattokinase and sulphydryl compounds for use in the treatment of inflammation
GB2525835A (en) Composition comprising a diindolymethane and a retinoid to treat a skin condition
WO2015013709A3 (en) Compositions for treating skin thickening
EA201500778A1 (en) COMPOSITION FOR SKIN CARE
BR112015006272A2 (en) '' cosmetic use, compounding, cosmetic composition and method of cosmetic treatment ''
SG178967A1 (en) Antimicrobial compositions and products